BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7851230)

  • 21. [Metabolic syndrome-x at the turn of the millennium (Theoretical aspects with practical consequences)].
    Halmos T; Jermendy G
    Orv Hetil; 2000 Dec; 141(50):2701-9. PubMed ID: 11189676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
    Rett K; Wicklmayr M; Standl E
    Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance in systemic hypertension: pharmacotherapeutic implications.
    Mediratta S; Fozailoff A; Frishman WH
    J Clin Pharmacol; 1995 Oct; 35(10):943-56. PubMed ID: 8568012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
    Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
    Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].
    Greco D; Sinagra D
    G Ital Cardiol; 1995 Feb; 25(2):207-16. PubMed ID: 7642026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin resistance and atherosclerosis].
    Nunes JS; Correia LG; Corrêa JN
    Acta Med Port; 2000; 13(4):203-10. PubMed ID: 11155488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension and insulin resistance in obese type 2 diabetic Wistar fatty rat].
    Suzuki M; Odaka H
    Nihon Rinsho; 2003 Jul; 61(7):1119-23. PubMed ID: 12877072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Visceral fat syndrome].
    Tokunaga K; Nakamura T; Kubo M; Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1831-5. PubMed ID: 1479226
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin resistance syndrome.
    Cheng TO
    South Med J; 1998 Jul; 91(7):697. PubMed ID: 9671849
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic options for treatment of cardiometabolic risk].
    Stokić E; Tomić-Naglić D; Derić M; Jorga J
    Med Pregl; 2009; 62 Suppl 3():54-8. PubMed ID: 19702117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal.
    Elliott TG; Viberti G
    Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):1079-103. PubMed ID: 8304914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P; Korenman S; Davis S
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperinsulinemia in hypertension: associations with race, abdominal obesity, and hyperlipidemia.
    Spangler JG; Bell RA; Summerson JH; Konen JC
    Arch Fam Med; 1998; 7(1):53-6. PubMed ID: 9443700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease].
    Cullen P; Assmann G
    Dtsch Med Wochenschr; 2000 Jul; 125(28-29):881-7. PubMed ID: 10943220
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiology of hypertension and insulin resistance syndrome.
    Haffner SM
    J Hypertens Suppl; 1997 Jan; 15(1):S25-30. PubMed ID: 9050982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise and the metabolic syndrome.
    Eriksson J; Taimela S; Koivisto VA
    Diabetologia; 1997 Feb; 40(2):125-35. PubMed ID: 9049471
    [No Abstract]   [Full Text] [Related]  

  • 40. Dyslipidemia of central obesity and insulin resistance.
    Brunzell JD; Hokanson JE
    Diabetes Care; 1999 Apr; 22 Suppl 3():C10-3. PubMed ID: 10189557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.